The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Sebastian F Schoppmann |
| Publication date | July 22, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |